Insight Molecular Diagnostics (IMDX) Cash from Operations (2015 - 2026)
Insight Molecular Diagnostics (IMDX) posted Cash from Operations of 7639000.0 for Q1 2026, down 37.76% sequentially from 5545000.0 in Q4 2025, and down 30.83% YoY from 11043357.51 in Q1 2025.
Insight Molecular Diagnostics (IMDX) Cash from Operations (2015 - 2026) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 12 years of Cash from Operations data on file, last reported at 7639000.0 in Q1 2026.
- Quarterly Cash from Operations fell 30.83% year-over-year to 7639000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 23984000.0 (down 5.67% YoY) and the FY2025 annual result came in at 22184000.0, down 7.23% from the prior year.
- Cash from Operations eased to 7639000.0 in Q1 2026 per IMDX's latest filing, from 5545000.0 in the prior quarter.
- The five-year high for Cash from Operations was 3769000.0 in Q3 2023, with the low at 13277000.0 in Q1 2022.
- Average Cash from Operations over 5 years is 7023823.53, with a median of 5978000.0 recorded in 2024.
- Year-over-year, Cash from Operations jumped 66.93% in 2023 and slumped 52.45% in 2025.
- Insight Molecular Diagnostics' Cash from Operations stood at 9648000.0 in 2022, then jumped by 54.15% to 4424000.0 in 2023, then slipped by 20.95% to 5351000.0 in 2024, then slipped by 3.63% to 5545000.0 in 2025, then tumbled by 37.76% to 7639000.0 in 2026.
- Business Quant data shows IMDX's Cash from Operations at 7639000.0 in Q1 2026, 5545000.0 in Q4 2025, and 4502000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -3.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.19 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.32 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 266.25 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 40.17 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 277.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 618.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 289.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 139.79 Mn |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 | -7.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.64 Mn |
| Mar 31, 2026 | -7.64 Mn |
| Dec 31, 2025 | -5.55 Mn |
| Dec 31, 2025 | -5.55 Mn |
| Sep 30, 2025 | -4.50 Mn |
| Sep 30, 2025 | -4.50 Mn |
| Jun 30, 2025 | -6.30 Mn |
| Jun 30, 2025 | -6.30 Mn |
| Mar 31, 2025 | -5.84 Mn |
| Mar 31, 2025 | -5.84 Mn |
| Dec 31, 2024 | -5.35 Mn |
| Dec 31, 2024 | -5.35 Mn |
| Sep 30, 2024 | -5.53 Mn |
| Sep 30, 2024 | -5.53 Mn |
| Jun 30, 2024 | -5.98 Mn |
| Jun 30, 2024 | -5.98 Mn |
| Mar 31, 2024 | -3.83 Mn |
| Mar 31, 2024 | -3.83 Mn |
| Dec 31, 2023 | -4.42 Mn |
| Dec 31, 2023 | -4.42 Mn |